Certified by Founder Lodge
adMare BioInnovations
Canada - ND
INVESTOR
1 Disclosed Funding Rounds $142,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Ca
| Company | Date | Round | Raised |
|---|---|---|---|
Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
Specific Biologics |
October, 17 ,2023 | Unknown |
Abdera Therapeutics
Specific Biologics
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Overstory | $43,000,000 | (Nov 27, 2025)
Procure Ai | $13,000,000 | (Nov 27, 2025)
Parallax Worlds | $4,900,000 | (Nov 27, 2025)
AUGMENTT | $18,000,000 | (Nov 27, 2025)
SubImage (YC W25) | $4,200,000 | (Nov 27, 2025)